Euglycemic DKA on an SGLT2 inhibitor
A normal glucose that hides a ketoacidosis — rare but high-risk during fasting, acute illness, perioperative periods, dehydration, or low-carbohydrate intake.
A normal glucose that hides a ketoacidosis — rare but high-risk during fasting, acute illness, perioperative periods, dehydration, or low-carbohydrate intake.
Integrating biopsy pattern with albumin, nephrotic features, and the hyperfiltration phenotype to avoid misclassification.
Low or high muscle mass and the case for cystatin C and the CKD-EPI 2021 combined equation.
Dose, monitoring, and volume/electrolyte surveillance when starting an incretin in reduced eGFR.
Reconciling weight-loss goals with protein and muscle preservation under renal replacement therapy.
Choosing between incretins and surgery as a bridge to listing, and planning peri-transplant management.